Good Manufacturing Practice and Good Distribution Practice Consultative Committee

The Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Consultative Committee discusses the manufacture and wholesale distribution of medicines.

The GMP and GDP Consultative Committee is an informal committee established to discuss matters relating to the manufacture and wholesale distribution of medicines for human use between:

  • the Medicines and Healthcare products Regulatory Agency (MHRA)
  • other governmental departments
  • the devolved administrations
  • relevant trade associations

Minutes and agendas

Meeting: 31 March 2017

Agenda for March 2017 meeting (PDF, 143KB, 2 pages)

Note of March 2017 meeting (PDF, 1.02MB, 12 pages)

Meeting: 7 October 2016

Agenda for October 2016 meeting (PDF, 58.5KB, 2 pages)

Note of October 2016 meeting (PDF, 2.01MB, 10 pages)

Meeting: 18 April 2016

Note of April 2016 meeting (PDF, 1.35MB, 10 pages)

Agenda for meeting on 18 April 2016 (PDF, 54.6KB, 2 pages)

Meeting: 30 October 2015

Note of October 2015 meeting (PDF, 14MB, 13 pages)

Agenda for meeting on 30 October 2015 (PDF, 135KB, 2 pages)

Meeting: 8 May 2015

Note of May 2015 meeting (PDF, 3.44MB, 11 pages)

Agenda for meeting on 8 May 2015 (PDF, 53.5KB, 2 pages)

Meeting: 17 October 2014

Note of October 2014 meeting (PDF, 5.59MB, 12 pages)

Agenda for meeting on 18 October 2014 (PDF, 134KB, 2 pages)

Contact details

chris.groutides@mhra.gsi.gov.uk